Publication Name	World Journal of Clinical Cases
Manuscript ID	51210
Country	Japan

Received	2019-09-02 15:14
Peer-Review Started	2019-09-02 15:14
To Make the First Decision
Return for Revision	2019-11-13 07:08
Revised	2019-11-27 11:13
Second Decision	2019-11-29 09:19
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2019-11-30 03:37
Articles in Press	2019-11-30 03:37
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2019-12-18 01:55
Publish the Manuscript Online	2019-12-25 11:24

ISSN	2307-8960 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2019 Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, Research & Experimental
Manuscript Type	Case Report
Article Title	Successful treatment of warfarin-induced skin necrosis using oral rivaroxaban: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Momoka Kamada and Tsuneaki Kenzaka
ORCID	Author(s) ORCID Number Momoka Kamada http://orcid.org/0000-0001-6396-9271 Tsuneaki Kenzaka http://orcid.org/0000-0002-3120-6605
Funding Agency and Grant Number
Corresponding Author	Tsuneaki Kenzaka, MD, PhD, Professor, Division of Community Medicine and Career Development, Kobe University Graduate School of Medicine, 2-1-5, Arata-cho, Hyogo-ku, Kobe 652-0032, Hyogo, Japan. smile.kenzaka@jichi.ac.jp
Key Words	Skin necrosis; Warfarin; Heparin; Rivaroxaban; Systemic lupus erythematosus; Case report
Core Tip	We present a serious case of warfarin-induced skin necrosis that was successfully treated with oral rivaroxaban, a factor Xa inhibitor. Administration of direct oral anticoagulants instead of warfarin is important in patients with decreased protein S and C activity.
Publish Date	2019-12-25 11:24
Citation	Kamada M, Kenzaka T. Successful treatment of warfarin-induced skin necrosis using oral rivaroxaban: A case report. World J Clin Cases 2019; 7(24): 4285-4291
URL	https://www.wjgnet.com/2307-8960/full/v7/i24/4285.htm
DOI	https://dx.doi.org/10.12998/wjcc.v7.i24.4285

Full Article (PDF)	WJCC-7-4285.pdf
Full Article (Word)	WJCC-7-4285.docx
Manuscript File	51210-Review.docx
Answering Reviewers	51210-Answering reviewers.pdf
Audio Core Tip	51210-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	51210-Conflict-of-interest statement.pdf
Copyright License Agreement	51210-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s)	51210-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	51210-Language certificate.pdf
Peer-review Report	51210-Peer-review(s).pdf
Scientific Misconduct Check	51210-Scientific misconduct check.pdf
Scientific Editor Work List	51210-Scientific editor work list.pdf